Mark Holterman

2.7k total citations
65 papers, 1.9k citations indexed

About

Mark Holterman is a scholar working on Surgery, Immunology and Genetics. According to data from OpenAlex, Mark Holterman has authored 65 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 33 papers in Surgery, 24 papers in Immunology and 13 papers in Genetics. Recurrent topics in Mark Holterman's work include T-cell and B-cell Immunology (17 papers), Immunotherapy and Immune Responses (16 papers) and Immune Cell Function and Interaction (14 papers). Mark Holterman is often cited by papers focused on T-cell and B-cell Immunology (17 papers), Immunotherapy and Immune Responses (16 papers) and Immune Cell Function and Interaction (14 papers). Mark Holterman collaborates with scholars based in United States, United Kingdom and Vietnam. Mark Holterman's co-authors include Bellur S. Prabhakar, Chenthamarakshan Vasu, Víctor H. Engelhard, Alexander Pereboev, David T. Curiel, Allen F. Browne, Giuliano Testa, Herand Abcarian, Enrico Benedetti and Ai‐Xuan L. Holterman and has published in prestigious journals such as Proceedings of the National Academy of Sciences, The Journal of Immunology and PLoS ONE.

In The Last Decade

Mark Holterman

63 papers receiving 1.9k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mark Holterman United States 25 634 634 447 382 233 65 1.9k
A. B. Peck United States 30 429 0.7× 747 1.2× 557 1.2× 554 1.5× 137 0.6× 57 2.4k
Janette Furuzawa‐Carballeda Mexico 26 510 0.8× 653 1.0× 200 0.4× 387 1.0× 189 0.8× 91 2.0k
Haluk Barbaros Oral Türkiye 27 238 0.4× 496 0.8× 350 0.8× 673 1.8× 276 1.2× 96 2.1k
Yutaka Kanamori Japan 22 1.0k 1.6× 664 1.0× 182 0.4× 328 0.9× 109 0.5× 154 2.2k
W. Dwayne Lawrence United States 29 443 0.7× 205 0.3× 256 0.6× 549 1.4× 351 1.5× 120 2.5k
H. WORSAAE Denmark 10 224 0.4× 763 1.2× 241 0.5× 262 0.7× 100 0.4× 12 1.8k
Atsuhiro Ogaẃa Japan 19 363 0.6× 1.2k 1.9× 524 1.2× 591 1.5× 380 1.6× 56 2.3k
Yehuda Shoenfeld Israel 23 168 0.3× 918 1.4× 207 0.5× 282 0.7× 94 0.4× 64 2.5k
Danielle Canioni France 20 393 0.6× 491 0.8× 436 1.0× 167 0.4× 273 1.2× 49 1.5k
Jean Dudler Switzerland 26 205 0.3× 1.1k 1.7× 282 0.6× 580 1.5× 218 0.9× 97 2.8k

Countries citing papers authored by Mark Holterman

Since Specialization
Citations

This map shows the geographic impact of Mark Holterman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Holterman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Holterman more than expected).

Fields of papers citing papers by Mark Holterman

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark Holterman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Holterman. The network helps show where Mark Holterman may publish in the future.

Co-authorship network of co-authors of Mark Holterman

This figure shows the co-authorship network connecting the top 25 collaborators of Mark Holterman. A scholar is included among the top collaborators of Mark Holterman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark Holterman. Mark Holterman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Bhattacharya, Palash, Medha Singh, Muthusamy Thiruppathi, et al.. (2015). Dual Role of GM-CSF as a Pro-Inflammatory and a Regulatory Cytokine: Implications for Immune Therapy. Journal of Interferon & Cytokine Research. 35(8). 585–599. 202 indexed citations
2.
Holterman, Ai‐Xuan L., Grace Guzman, Giamila Fantuzzi, et al.. (2013). Nonalcoholic fatty liver disease in severely obese adolescent and adult patients. Obesity. 21(3). 591–597. 71 indexed citations
3.
4.
Holterman, Mark, Ai‐Xuan L. Holterman, & Allen F. Browne. (2012). Pediatric Obesity. Surgical Clinics of North America. 92(3). 559–582. 8 indexed citations
5.
Jayaraman, Sundararajan, Sung Won Kwon, Rajvir Singh, et al.. (2010). Transfusion of Nonobese Diabetic Mice with Allogeneic Newborn Blood Ameliorates Autoimmune Diabetes and Modifies the Expression of Selected Immune Response Genes. The Journal of Immunology. 184(6). 3008–3015. 12 indexed citations
6.
Karumuthil‐Melethil, Subha, Nicolas Pérez, Ruobing Li, et al.. (2010). Dendritic Cell-Directed CTLA-4 Engagement during Pancreatic β Cell Antigen Presentation Delays Type 1 Diabetes. The Journal of Immunology. 184(12). 6695–6708. 17 indexed citations
7.
Zhao, Yong, et al.. (2010). New type of human blood stem cell: a double-edged sword for the treatment of type 1 diabetes. Translational research. 155(5). 211–216. 17 indexed citations
8.
Lee, David D., Edward F. Hollinger, Anthony W. Kim, & Mark Holterman. (2009). Persistent hypoglycemia in a child with a gastrocolic fistula—an unexpected presentation of leucine-sensitive hypoglycemia. Journal of Pediatric Surgery. 44(4). e13–e16. 2 indexed citations
10.
Pérez, Nicolas, Subha Karumuthil‐Melethil, Ruobing Li, et al.. (2008). Preferential Costimulation by CD80 Results in IL-10-Dependent TGF-β1+-Adaptive Regulatory T Cell Generation. The Journal of Immunology. 180(10). 6566–6576. 39 indexed citations
11.
Li, Ruobing, Nicolas Pérez, Subha Karumuthil‐Melethil, et al.. (2007). Enhanced Engagement of CTLA-4 Induces Antigen-Specific CD4+CD25+Foxp3+ and CD4+CD25− TGF-β1+ Adaptive Regulatory T Cells. The Journal of Immunology. 179(8). 5191–5203. 42 indexed citations
12.
Testa, Giuliano, et al.. (2006). Pattern of growth after pediatric living‐donor small bowel transplantation. Pediatric Transplantation. 10(6). 701–706. 9 indexed citations
13.
Vasu, Chenthamarakshan, Bellur S. Prabhakar, & Mark Holterman. (2004). Targeted CTLA-4 Engagement Induces CD4+CD25+CTLA-4high T Regulatory Cells with Target (Allo)antigen Specificity. The Journal of Immunology. 173(4). 2866–2876. 51 indexed citations
14.
Testa, Giuliano, Fabrizio Panaro, Stefano Schena, et al.. (2004). Living Related Small Bowel Transplantation. Annals of Surgery. 240(5). 779–784. 50 indexed citations
15.
Jelnin, Vladimir, Carlos Ruíz, Eunice John, et al.. (2004). Electron beam CT scan is a valuable and safe imaging tool for the pediatric surgical patient. Journal of Pediatric Surgery. 39(12). 1859–1862. 3 indexed citations
16.
Vasu, Chenthamarakshan, et al.. (2003). Absence of IL-4, and Not Suppression of the Th2 Response, Prevents Development of Experimental Autoimmune Graves’ Disease. The Journal of Immunology. 170(4). 2195–2204. 47 indexed citations
18.
Agadjanyan, Michael G., Michael A. Chattergoon, Mark Holterman, et al.. (2003). Costimulatory Molecule Immune Enhancement in a Plasmid Vaccine Model Is Regulated in Part Through the Ig Constant-Like Domain of CD80/86. The Journal of Immunology. 171(8). 4311–4319. 15 indexed citations
20.
Engelhard, Víctor H., John R. Yannelli, Glen A. Evans, Scott F. Walk, & Mark Holterman. (1985). Construction of novel class I histocompatibility antigens by interspecies exon shuffling.. The Journal of Immunology. 134(6). 4218–4225. 30 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026